RxDoctor Payments Data

Matthew Pitre, DPM

Foot Surgery · Huntington, NYNPI 1063032019

Payments from drug & device makers

What this record shows

16 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 36.8% of the total. 2025 is the largest year on record at $1,828, more than ten times the $158 reported in 2021.

$3,566in general payments, 2019–2025

Across 58 payments — averaging $61.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$1K
  • Stryker$1K
  • DJO, LLC$183
  • Orthofix Medical, Inc.$157
  • Bioventus LLC$109
  • Tactile Systems Technology Inc$97
  • plus $420 from 10 others

What the payments were for

  • Travel & lodging$1,67647%
  • Food & beverage$1,89053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,566 in reported general payments places this provider in the 80th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$131,674
Medicare patients
541
Services billed
1,998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate76$2,473
Ciclopirox21$684
Ketoconazole11$680
Silver Sulfadiazine24$217
Doxycycline Hyclate24$150

Paid to pharmacies, not to this prescriber.

Other foot surgery in Huntington

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →